The 4100 Group

Venture Capital Firm

The 4100 Group
Contact

The 4100 Group

The 4100 Group

Name
This field is hidden when viewing the form

4100DX stands at the forefront of health innovation and patient capital, uniquely merging long-term investment with transformative healthcare advancements.

Contact

Team

  • Scott Lancaster
    Managing Director
  • Scott Mclean
    Managing Director
  • Mariya Filipova
    Managing Director

Stages of Investment

  • Growth/Expansion
  • Seed
  • Startup/Early

Sectors of Investment

  • Life Sciences
  • Medical Device Technology

IT Subsectors

  • Not Applicable

Life Science Subsectors

  • Devices
  • Diagnostics
  • Healthcare Services

Details

  • Michigan Investment Professionals3
  • Worldwide Investment Professionals7
  • Assets Under Management $35,000,000
  • Funds Managed (Current & Historical)3
  • Actively InvestingYes
  • Preferred Initial Investment$500,000 - $3,000,000

The most timely & relevant email you will get about Michigan’s investment & entrepreneurial ecosystem.

From public policy to the new ideas and breakthrough investment opportunities, MVCA will keep your finger on the pulse of must know information in the industry.

Newsletter

This field is for validation purposes and should be left unchanged.